Exact Mass: 635.3154662
Exact Mass Matches: 635.3154662
Found 149 metabolites which its exact mass value is equals to given mass value 635.3154662,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Glycylserylprolylmethionylphenylalanylvalinamide
Glycylserylprolylmethionylphenylalanylvalinamide is found in mollusks. Glycylserylprolylmethionylphenylalanylvalinamide is isolated from Mytilus edulis (blue mussel). Isolated from Mytilus edulis (blue mussel). Glycylserylprolylmethionylphenylalanylvalinamide is found in mollusks.
PC(2:0/PGF2alpha)
PC(2:0/PGF2alpha) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(2:0/PGF2alpha), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Prostaglandin F2alpha at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).
PC(PGF2alpha/2:0)
PC(PGF2alpha/2:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(PGF2alpha/2:0), in particular, consists of one chain of one Prostaglandin F2alpha at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).
PC(2:0/PGE1)
PC(2:0/PGE1) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(2:0/PGE1), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Prostaglandin E1 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).
PC(PGE1/2:0)
PC(PGE1/2:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(PGE1/2:0), in particular, consists of one chain of one Prostaglandin E1 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).
PC(2:0/PGD1)
PC(2:0/PGD1) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(2:0/PGD1), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Prostaglandin D1 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).
PC(PGD1/2:0)
PC(PGD1/2:0) is an oxidized phosphatidylcholine (PC or GPCho). Oxidized phosphatidylcholines are glycerophospholipids in which a phosphorylcholine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylcholines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PC(PGD1/2:0), in particular, consists of one chain of one Prostaglandin D1 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PCs can be synthesized via three different routes. In one route, the oxidized PC is synthetized de novo following the same mechanisms as for PCs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidated acyl chains with an oxidated acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PC backbone, mainely through the action of LOX (PMID: 33329396).
13alpha,16alpha,20-triacetoxy-14alpha-benzoyloxy-himbosan-18-oic acid methyl ester|13alpha,16alpha,20-Triacetoxy-14alpha-benzoyloxy-himbosan-18-saeure-methylester|Himbosin
C35H41NO10 (635.2730326000001)
Phe Phe His Trp
Phe Phe Trp His
Phe His Phe Trp
Phe His Trp Phe
Phe Lys Arg Trp
Phe Lys Trp Arg
Phe Gln Arg Trp
C31H41N9O6 (635.3179646000001)
Phe Gln Trp Arg
C31H41N9O6 (635.3179646000001)
Phe Arg Lys Trp
Phe Arg Gln Trp
C31H41N9O6 (635.3179646000001)
Phe Arg Trp Lys
Phe Arg Trp Gln
C31H41N9O6 (635.3179646000001)
Phe Trp Phe His
Phe Trp His Phe
Phe Trp Lys Arg
Phe Trp Gln Arg
C31H41N9O6 (635.3179646000001)
Phe Trp Arg Lys
Phe Trp Arg Gln
C31H41N9O6 (635.3179646000001)
His Phe Phe Trp
His Phe Trp Phe
His Trp Phe Phe
Lys Phe Arg Trp
Lys Phe Trp Arg
Lys Arg Phe Trp
Lys Arg Trp Phe
Lys Trp Phe Arg
Lys Trp Arg Phe
Lys Tyr Tyr Tyr
C33H41N5O8 (635.2954986000001)
Gln Phe Arg Trp
C31H41N9O6 (635.3179646000001)
Gln Phe Trp Arg
C31H41N9O6 (635.3179646000001)
Gln Arg Phe Trp
C31H41N9O6 (635.3179646000001)
Gln Arg Trp Phe
C31H41N9O6 (635.3179646000001)
Gln Trp Phe Arg
C31H41N9O6 (635.3179646000001)
Gln Trp Arg Phe
C31H41N9O6 (635.3179646000001)
Arg Phe Lys Trp
Arg Phe Gln Trp
C31H41N9O6 (635.3179646000001)
Arg Phe Trp Lys
Arg Phe Trp Gln
C31H41N9O6 (635.3179646000001)
Arg Lys Phe Trp
Arg Lys Trp Phe
Arg Gln Phe Trp
C31H41N9O6 (635.3179646000001)
Arg Gln Trp Phe
C31H41N9O6 (635.3179646000001)
Arg Trp Phe Lys
Arg Trp Phe Gln
C31H41N9O6 (635.3179646000001)
Arg Trp Lys Phe
Arg Trp Gln Phe
C31H41N9O6 (635.3179646000001)
Trp Phe Phe His
Trp Phe His Phe
Trp Phe Lys Arg
Trp Phe Gln Arg
C31H41N9O6 (635.3179646000001)
Trp Phe Arg Lys
Trp Phe Arg Gln
C31H41N9O6 (635.3179646000001)
Trp His Phe Phe
Trp Lys Phe Arg
Trp Lys Arg Phe
Trp Gln Phe Arg
C31H41N9O6 (635.3179646000001)
Trp Gln Arg Phe
C31H41N9O6 (635.3179646000001)
Trp Arg Phe Lys
Trp Arg Phe Gln
C31H41N9O6 (635.3179646000001)
Trp Arg Lys Phe
Trp Arg Gln Phe
C31H41N9O6 (635.3179646000001)
Tyr Lys Tyr Tyr
C33H41N5O8 (635.2954986000001)
Tyr Tyr Lys Tyr
C33H41N5O8 (635.2954986000001)
Tyr Tyr Tyr Lys
C33H41N5O8 (635.2954986000001)
Glycylserylprolylmethionylphenylalanylvalinamide
[(2S,3R,4S,5S,6R)-4-azaniumyl-2-[(1S,2S,3R,4S,6R)-4-azaniumyl-3-[(2R,3R,6S)-3-azaniumyl-6-(azaniumylmethyl)oxan-2-yl]oxy-6-[[(2S)-4-azaniumyl-2-hydroxybutanoyl]amino]-2-hydroxycyclohexyl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-3-yl] phosphate
[2-[[hydroxy-[2-(4-hydroxy-1,3-thiazol-3-ium-3-yl)ethoxy]phosphoryl]oxymethyl]oxolan-2-yl]methyl N-octadecylcarbamate
[4-tert-butyl-2-[(E,3E)-3-[1-(5-carboxypentyl)-3,3-dimethyl-5-sulfoindol-2-ylidene]prop-1-enyl]chromen-7-ylidene]-diethylazanium
[2-tert-butyl-4-[(E,3E)-3-[1-(5-carboxypentyl)-3,3-dimethyl-5-sulfoindol-2-ylidene]prop-1-enyl]chromen-7-ylidene]-diethylazanium
N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydodeca-4,8-dien-2-yl]hexanamide
N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadeca-4,8-dien-2-yl]acetamide
N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxypentadeca-4,8-dien-2-yl]propanamide
N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetradeca-4,8-dien-2-yl]butanamide
N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytrideca-4,8-dien-2-yl]pentanamide
[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
PE(29:7)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(2e)-2-[4,5-dihydroxy-2-(2-{[2-(4-hydroxyphenyl)ethyl]-c-hydroxycarbonimidoyl}ethyl)phenyl]-3-(4-hydroxy-3,5-dimethoxyphenyl)-n-{4-[(1-hydroxyethylidene)amino]butyl}prop-2-enimidic acid
8-(2-{6-amino-1,1,3,3-tetramethyl-4h,9h-indeno[2,1-c]pyran-7-yl}-2-oxoethyl)-10a-hydroxy-3-(2-hydroxypropan-2-yl)-6a,7-dimethyl-2-oxo-3h,4ah,5h,6h,8h,9h,10h-naphtho[2,1-b]pyran-7-carboxylic acid
(3r,4as,6ar,7s,8s,10as)-8-(2-{6-amino-1,1,3,3-tetramethyl-4h,9h-indeno[2,1-c]pyran-7-yl}-2-oxoethyl)-10a-hydroxy-3-(2-hydroxypropan-2-yl)-6a,7-dimethyl-2-oxo-3h,4ah,5h,6h,8h,9h,10h-naphtho[2,1-b]pyran-7-carboxylic acid
aconitum coreanum alkaloid
C35H41NO10 (635.2730326000001)
{"Ingredient_id": "HBIN014584","Ingredient_name": "aconitum coreanum alkaloid","Alias": "NA","Ingredient_formula": "C35H41NO10","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7189","PubChem_id": "NA","DrugBank_id": "NA"}